Heparin-induced thrombocytopenia (HIT) is a clinically significant immune-mediated adverse reaction to heparin therapy. It is typified by a reduction in circulating platelets while paradoxically ...

A team of researchers developed 3 quality improvement measures embedded in electronic health records (EHRs) to improve care delivery in patients with heparin-induced thrombocytopenia. HIT is known as ...

Due to the potential for life- and limb-threatening complications, effective and immediate management of HIT is vital. When HIT is suspected, it is imperative to remove all forms of heparin, including ...

Purpose: A case of heparin-induced thrombocytopenia (HIT) complicated by warfarin-induced skin necrosis (WISN) is reported. Summary: A patient with a history of hypertension, heart failure, and ...

Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HIT It is the first and only potent, highly selective inhibitor of human 12-LOX in clinical ...

Researchers at McMaster University have discovered that a rare but dangerous reaction to a widely used blood thinner is caused by a single antibody—overturning decades of medical misunderstanding and ...

Detailed price information for Cadrenal Therapeutics Inc (CVKD-Q) from The Globe and Mail including charting and trades.

TCT 378: Contemporary Analysis and Outcomes of Orbital Atherectomy (OA) and Rotational Atherectomy (RA) for Inpatient Percutaneous Coronary Intervention (PCI) Receive the the latest news, research, ...

The heparin frequently given before percutaneous coronary intervention (PCI) should be pushed to as early as possible in patients with ST-segment elevation myocardial infarction (STEMI), according to ...

PONTE VEDRA, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of ...